Blue Bird (BLBD) Q2 2026 Earnings Transcript

Blue Bird posted record fiscal Q2 adjusted EBITDA of $51 million and adjusted free cash flow of $40 million, while revenue was $353 million and buses sold totaled 2,148 units, slightly below last year. Management raised FY2026 revenue guidance to $1.725 billion-$1.775 billion and adjusted EBITDA guidance to $235 million-$255 million after closing the MicroBird acquisition, which expands the addressable market by 78%. The company also reconfirmed an $80 million DOE MES grant, highlighted a $100 million buyback program, and said tariff impacts are being managed to a margin-neutral outcome.

Analysis

BLBD is transitioning from a cyclical OEM into a pricing-and-mix compounder with multiple self-reinforcing wedges: backlog quality, tariff pass-through, and a larger installed base monetizing parts. The key second-order effect is that the business is getting less dependent on raw unit growth; even if production days wobble, a tight backlog plus a richer EV/alt-power mix can keep EBITDA and FCF expanding. That makes the stock less about school-bus volume beta and more about margin control plus capital allocation optionality.

The MicroBird consolidation is the bigger strategic change than the quarter itself. It expands BLBD’s addressable market, but more importantly it adds a new growth narrative that can support a higher multiple if execution remains clean; however, it also introduces integration and contract-ramp risk just as management is effectively maxed out on one-shift capacity. The market may be underestimating the operating leverage from a new plant designed around the largest product category, but that benefit is back-half/2028 economics, not a near-term EPS catalyst.

The real watch item is policy. If clean-bus funding is reallocated away from the current structure, the mix could swing toward propane and away from EV subsidy intensity; that is not necessarily bad for BLBD because it is uniquely positioned in propane, but it could compress the headline EV growth story that has supported the multiple. The nearer-term risk is that the equity has already been rewarded for perfect execution; after fourteen straight beats and guidance raises, any stumble in integration, backlog conversion, or tariff offset timing would hit a richly rerated name hard.

Key Decisions for Investors

• Long BLBD on pullbacks over the next 2-6 weeks; target a trade around post-earnings digestion rather than chasing strength. Risk/reward is favorable if investors re-rate the name on mid-teens EBITDA margins and 2028 plant optionality, but size modestly because the easy beat-and-raise setup is now in the price.
• Use a pairs trade: long BLBD / short a less-disciplined industrial or specialty OEM with weaker pricing power and lower FCF conversion. The thesis is that BLBD’s margin durability and capital returns will outperform over the next 1-2 quarters even if unit growth slows.
• Buy BLBD Jan-2027 call spreads or call diagonals to express the 12-18 month MicroBird/plant thesis with limited downside. The catalyst path is midyear contract ramp updates plus continued FCF buybacks; avoid outright shares if policy headlines may create volatility.
• If already long, hedge with short-dated puts into any rally ahead of EPA/clean-bus policy headlines. The stock is vulnerable to multiple compression if the market decides EV subsidy assumptions were too aggressive.
• Monitor BLBD versus peers in transportation equipment over the next 1-3 months; if relative strength persists while volume growth stays muted, add only on confirmation that backlog converts without margin leakage.